Indo Rama Synthetics reported a consolidated net profit of ₹63.74 crore for the quarter ended June 30, 2026, marking a 20.8% year-on-year increase from ₹52.75 crore in Q1FY26. Despite a significant decline in total income from operations to ₹940.20 crore from ₹1,308.56 crore, driven by volume impacts from West Asia geopolitical issues, the company achieved substantial margin expansion. The Board of Directors approved the unaudited standalone and consolidated financial results on July 29, 2026, highlighting improved operational efficiency and cost management as key drivers of profitability amid volatile market conditions.

The financial results were reviewed by the Audit Committee and approved by the Board in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The figures have been prepared in accordance with Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013. Statutory auditors SS Kothari Mehta & Co. LLP reviewed the results. The company also published extracts of the financial results in Business Standard (English) and Loksatta (Marathi) on July 30, 2026, pursuant to Regulation 47 of the SEBI LODR Regulations.

Consolidated Financial Performance

Operational efficiency improved significantly despite lower top-line performance. Consolidated EBITDA rose to ₹145.99 crore (derived from margin application) from ₹97.00 crore in the prior year quarter, reflecting strong cost management and a favorable product mix. The EBITDA margin expanded to 15.57% from 7.43% in Q1FY26. Standalone net profit stood at ₹33.75 crore, up from ₹32.31 crore in the same period last year. Finance costs decreased slightly to ₹29.38 crore from ₹29.03 crore, while foreign exchange fluctuation losses remained contained at ₹2.91 crore.

The following table summarises the key consolidated financial metrics for the quarter:

Corporate Governance Updates

The Board re-constituted the Stakeholders Relationship Committee under Section 178 of the Companies Act, 2013, appointing Mr. Ravi Capoor as Chairman. Key committee members include Executive Directors Om Prakash Lohia and Vishal Lohia, Whole-time Director Sanjay Gupta, Non-executive Non-Independent Director Vipin Kumar, and Independent Director Atim Kabra. The Board also amended the notice for the 40th Annual General Meeting, scheduled for September 8, 2026, due to changes in board composition.

Leadership Re-appointments

Subject to shareholder approval at the upcoming AGM, the Board approved the following re-appointments:

• Om Prakash Lohia: Re-appointed as Chairman and Managing Director for three years, effective December 26, 2026, to December 25, 2029.
• Dharmpal Agarwal: Re-appointed as Independent Director for five consecutive years, effective November 25, 2026, to November 24, 2031.

What the Numbers Show

The divergence between declining revenue and rising profitability highlights a margin-led performance strategy. While total revenue fell YoY due to external geopolitical headwinds affecting volumes, the EBITDA margin expanded substantially by over 800 basis points. This reflects Indo Rama Synthetics' ability to mitigate cost pressures through product mix optimisation, enabling higher absolute profits despite a smaller sales base. The stability in finance costs further supported bottom-line resilience.

Indo Rama Synthetics (India) Limited indo rama synthetics appointed Ambika Sharma and Atim Kabra as Additional Directors on July 27, 2026, enhancing its governance framework with seasoned professionals in international business strategy and financial markets. The Board of Directors approved the appointments through resolutions passed by circulation, subject to final ratification by shareholders at the ensuing Annual General Meeting. Both appointees join as Non-Executive Independent Directors, serving five-year terms from July 27, 2026, to July 26, 2031, and are not liable to retire by rotation.

The appointments were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III. The company also cited compliance with SEBI circular SEBVHO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026. Both directors were recommended by the Nomination and Remuneration Committee and are confirmed as not debarred or disqualified by any order of the Ministry of Corporate Affairs or SEBI.

Ambika Sharma joins as a Non-Executive Independent Director (Woman). She brings extensive experience from her roles as Director General - International at FICCI and Managing Director of the U.S.-India Business Council. Atim Kabra joins as a Non-Executive Independent Director, leveraging his background as Executive Director at Astra Microwave Products Ltd and his expertise in equity research and portfolio management with global institutions like ABN AMRO Bank. Neither director is related to the promoters or existing board members.

Committee Reconstitutions

The Board reconstituted three key committees to integrate the new directors:

Audit Committee Pursuant to Section 177 of the Companies Act, 2013 and Regulation 18 of the Listing Regulations, the committee now includes:

Nomination and Remuneration Committee Under Section 178 of the Companies Act, 2013 and Regulation 19 of the Listing Regulations:

Stakeholders and Relationship Committee Governed by Section 178 of the Companies Act, 2013 and Regulation 20 of the Listing Regulations:

The disclosures were filed with the National Stock Exchange of India Limited and BSE Limited by Ashok Yadav, Company Secretary and Compliance Officer.